Partnerships
Image
We are dedicated to building a better future for patients by developing a portfolio of differentiated and life-changing therapeutics for serious diseases with unmet need.
Our track record of successful in-licensing and out-licensing transactions underscores our commitment to innovation, speed, and strong collaboration. We are actively focused on expanding our pipeline with novel, high-impact programs and platforms.
If you share our vision for advancing impactful therapies, we’d love to explore potential partnership opportunities. Contact us today.
We are particularly interested in modalities, technologies or drug platforms that enable:
Image
Immunoscience
- Inducing immune tolerance
- Biomarker-based approaches to stratifying patients within larger heterogeneous diseases
- Combination therapeutics
Image
Cardiovascular
Treating inflammatory or orphan/niche cardiovascular conditions
Image
Discovery Platforms
- Rapid development potential from concept to IND
- Bioinformatic approaches to identify potential disease targets or responder populations